GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shinhung Co 004080.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

14,570

+0.14%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩102.61bn

FY2016FY2025

Net income

₩2.82bn

FY2016FY2025

Free cash flow

−₩1.59bn

FY2016FY2025

Shareholders' equity

₩115.40bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩102.61bn₩101.76bn₩112.44bn₩118.18bn₩126.85bn₩116.65bn₩123.01bn₩121.54bn₩121.15bn₩124.37bn
Gross profit₩31.95bn₩30.93bn₩36.04bn₩34.76bn₩37.03bn₩30.03bn₩30.74bn₩29.46bn₩31.37bn₩31.59bn
Research and development₩917.8m₩682.8m₩830.5m₩743.7m₩785.9m₩758.4m₩809.1m₩695.7m₩650.3m₩605.0m
Operating income₩7.09bn₩7.33bn₩12.17bn₩10.46bn₩20.49bn₩3.16bn₩3.00bn₩1.90bn₩4.81bn₩4.23bn
Net income₩2.82bn₩5.23bn₩9.23bn₩8.46bn₩13.45bn₩12.43bn₩2.04bn₩3.05bn₩3.17bn₩1.16bn
Diluted earnings per share295.79547.95967.36886.981,409.521,302.80214.23320.07332.05121.13

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩149.63bn₩141.43bn₩140.33bn₩140.62bn₩138.61bn₩146.18bn₩146.70bn₩132.69bn₩131.26bn₩131.53bn
Total liabilities₩33.63bn₩25.27bn₩26.44bn₩33.76bn₩37.20bn₩54.27bn₩58.74bn₩45.38bn₩44.89bn₩46.84bn
Debt₩1.90bn₩650.0m₩154.2m₩205.7m₩431.4m₩512.7m₩33.35bn₩17.67bn₩21.29bn₩23.80bn
Shareholders' equity₩115.40bn₩115.67bn₩113.89bn₩106.86bn₩101.42bn₩91.90bn₩87.95bn₩87.31bn₩86.37bn₩84.63bn
Shares outstanding10m10m10m10m10m10m10m10m10m10m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩1.93bn₩9.58bn₩7.64bn₩4.42bn₩3.34bn₩12.79bn₩907.6m₩1.98bn₩2.55bn₩8.17bn
Capital spending−₩3.52bn−₩3.94bn−₩5.98bn−₩3.46bn−₩1.98bn−₩20.26bn−₩16.19bn−₩3.56bn−₩1.02bn−₩845.2m
Free cash flow−₩1.59bn₩5.65bn₩1.66bn₩960.0m₩1.37bn−₩7.48bn−₩15.28bn−₩1.58bn₩1.53bn₩7.33bn
Dividends paid−₩2.57bn−₩2.50bn−₩2.45bn−₩2.25bn−₩1.90bn−₩1.15bn−₩1.15bn−₩1.15bn−₩1.15bn−₩1.15bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩26.28bn₩25.15bn₩30.35bn₩24.10bn₩24.54bn₩23.62bn₩26.69bn₩23.84bn
Gross profit₩9.62bn₩7.43bn₩9.47bn₩7.33bn₩8.20bn₩6.95bn₩8.23bn₩6.84bn
Operating income₩4.50bn₩805.6m₩434.4m₩1.49bn₩1.70bn₩1.03bn₩2.19bn₩898.5m
Net income₩3.93bn₩775.2m−₩312.5m₩965.3m₩1.89bn₩281.8m₩1.44bn₩1.05bn
Diluted earnings per share411.8181.24-32.75101.16197.8529.53150.74110.28
Cash from operations₩3.19bn−₩4.87bn₩603.0m−₩1.10bn₩1.39bn₩1.03bn₩5.31bn−₩2.44bn
Capital spending−₩1.44bn−₩181.0m−₩1.07bn−₩743.0m−₩730.0m−₩978.0m−₩890.0m−₩752.0m
Free cash flow₩1.75bn−₩5.05bn−₩463.0m−₩1.85bn₩664.0m₩56.0m₩4.42bn−₩3.19bn
Total assets₩157.24bn₩153.79bn₩149.63bn₩153.50bn₩149.31bn₩147.76bn₩141.43bn₩150.35bn
Debt₩1.52bn₩1.71bn₩1.90bn₩1.67bn₩2.00bn₩1.40bn₩650.0m₩800.0m
Shareholders' equity₩116.71bn₩113.34bn₩115.40bn₩115.92bn₩116.35bn₩114.74bn₩115.67bn₩115.00bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.6%-2.5%-2.0%
Operating income-12.1%17.6%0.8%
Net income-30.7%-25.7%-0.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin30.8%30.7%29.6%27.8%
Operating margin7.1%8.5%8.9%6.3%
Net margin3.9%5.9%7.6%4.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings47.326.114.816.711.58.444.432.233.485.0
Price to sales1.31.31.21.21.20.90.70.80.90.8

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year330.00430.00260.00240.00200.00200.00200.00200.00
  • 10-for-1 split · 22 Jul 1999
  • 6-for-5 split · 22 Nov 1993

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.